Aurigene is committed to provide end-to-end peptide synthesis services, from discovery to manufacturing, with core competencies ranging from simple linear peptides to complex forms.
At Aurigene Pharmaceutical Services, we design strategic approaches to improve druggability by improving bioavailability and ADME parameters. We provide end-to-end solutions from discovery to manufacturing.
Our portfolio of peptides ranges from simple side-chain modification upto 80 amino acids to backbone and side-chain modified peptides and derivatized peptides.